"Executive Summary Inherited Metabolic Disorders Testing Market :
Data Bridge Market Research analyses that the inherited metabolic disorders testing market is expected to reach USD 1125.15 million by 2030, which is USD 603.4 million in 2022, and is expected to undergo a CAGR of 8.1% during the forecast period 2023 to 2030.
For a powerful business growth, companies must take up...
"Executive Summary Hereditary Cancer Testing Market :
CAGR Value
Data Bridge Market Research analyzes that the global hereditary cancer testing market is expected to reach the value of USD 13,085.04 million by 2029, at a CAGR of 12.9% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
The Hereditary...
"Executive Summary Infantile Hemangioma Market :
CAGR Value
The infantile hemangioma market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 3.2% in the above-mentioned research forecast period. Increase in research and development related to the treatment of infantile hemangioma can drive...
"Executive Summary Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market :
Data Bridge Market Research analyses that the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes market, which is USD 5.62 billion in 2022, is expected to reach USD 11.28 billion by 2030, at a CAGR of 9.10% during the forecast period 2023 to 2030.
Breast Cancer 1 (BRCA1) and Breast Cancer 2...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek